Cipla to acquire 11.71% stake in Wellthy Therapeutics

Goldencross Pharma, a wholly-owned subsidiary of Cipla, has inked an agreement to acquire the minority stake in the Mumbai-based firm for a cash consideration of Rs 10.5 crore.

from Healthcare/Biotech-Industry-Economic Times http://bit.ly/2tqLEh9
via IFTTT